syringic acid has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afşar, E; Ağar, A; Aslan, M; Bülbül, M; Güzelad, Ö; Öğüt, E; Özkan, A; Parlak, H; Sinen, O; Yıldırım, FB | 1 |
| Hong, ZY; Liu, HR; Shi, XR; Zhang, YC; Zhu, YZ | 1 |
2 other study(ies) available for syringic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
Topics: Animals; Dopamine; Dopaminergic Neurons; Gallic Acid; Male; Motor Activity; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tandem Mass Spectrometry; Tyrosine 3-Monooxygenase | 2021 |
Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Topics: Animals; Behavior, Animal; Cell Line, Tumor; Cell Survival; Gallic Acid; Humans; Leonurus; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2011 |